TP53 and acute myeloid leukemia: Susceptibility to AC-4-130 varied in the tested AML cell lines with elevated susceptibility of the TP53-mutated secondary AML cell line SKM-1, intermediate susceptibility of the TP53 wild-type cell lines MOLM-13 and ML-2, as well as reduced susceptibility of the TP53 wild-type cell line OCI-AML3, the TP53 mutated MOLM-16, and the TP53 null cell line HL-60.